trending Market Intelligence /marketintelligence/en/news-insights/trending/mcc1zjfxygta-fww9wxdsw2 content esgSubNav
In This List

OncBioMune Pharmaceuticals appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


OncBioMune Pharmaceuticals appoints director

OncBioMune Pharmaceuticals Inc. added Neal Holcomb to its board.

Holcomb is president and owner of Holcomb CPA Firm P.A. and serves as a director at several private companies. He was also the certified public accountant for OncBioMune LLC, before the company went public.

Baton Rouge, La.-based OncBioMune Pharmaceuticals is developing proprietary cancer vaccine technology and targeted cancer therapies.